In the Human Protein Atlas (http://www.proteinatlas.org/) [21] database, more than 50% of the cases with ductal carcinoma of the breast show a decrease in tau expression, with the remaining cases showing no tau level changes. This evidence concerns the gene MAPT and breast ductal adenocarcinoma.